ATLANTA--(BUSINESS WIRE)--Inhibitex, Inc. (NASDAQ:INHX), a biopharmaceutical company focused on developing products to treat and prevent serious infectious diseases, announced today that Russell H. Plumb, president and chief executive officer of Inhibitex, Inc., and Joseph M. Patti, Ph.D., vice president of research and development and chief scientific officer, are scheduled to present at the following two conferences in May 2008:
